Literature DB >> 30850192

The ATAUD Study: The Need to Improve Adherence.

Carlota Rodríguez-García1, Tamara Lourido-Cebreiro1, Francisco-Javier González-Barcala2.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 30850192     DOI： 10.1016/j.arbres.2019.01.014

Source DB:  PubMed          Journal:  Arch Bronconeumol (Engl Ed)        ISSN： 0300-2896            Impact factor:   4.872


× No keyword cloud information.
  3 in total

1.  Real-life experience with benralizumab during 6 months.

Authors:  A Padilla-Galo; RCh Levy-Abitbol; C Olveira; B Valencia Azcona; M Pérez Morales; F Rivas-Ruiz; B Tortajada-Goitia; I Moya-Carmona; A Levy-Naon
Journal:  BMC Pulm Med       Date:  2020-06-29       Impact factor: 3.317

2.  Characteristics and treatment patterns of patients with asthma on multiple-inhaler triple therapy in Spain.

Authors:  Miriam Barrecheguren; Monica Monteagudo; Marc Miravitlles; Xavier Flor; Alexa Núñez; Jeisson Osorio; Xavier Muñoz; Iñigo Ojanguren
Journal:  NPJ Prim Care Respir Med       Date:  2022-03-10       Impact factor: 2.871

3.  Real-life cost-effectiveness of benralizumab in patients with severe asthma.

Authors:  A Padilla-Galo; A J García-Ruiz; R Ch Levy Abitbol; C Olveira; F Rivas-Ruiz; N García-Agua Soler; M Pérez Morales; B Valencia Azcona; B Tortajada-Goitia; I Moya-Carmona; A Levy-Naon
Journal:  Respir Res       Date:  2021-05-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.